Treating stress prevented new MS brain lesions

 

New Orleans, LA (July 16, 2012) – Research conducted by Jesus Lovera, MD, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has shown that stress management treatment significantly reduced the formation of new brain lesions in people with multiple sclerosis (MS) over the course of treatment. These lesions are markers of disease activity used to objectively measure disease status. The work is published ahead of print and is now available online in Neurology.

 

"Our research found that 77% of the patients undergoing stress management therapy remained free of lesions while they were in treatment compared to 55% of those in the control group," notes Dr. Jesus Lovera, an LSU Health Sciences Center New Orleans board certified neurologist whose research and practice focus on multiple sclerosis.

 

The research team studied 121 patients with relapsing forms of MS, most of whom are women. They were randomly assigned to receive stress management therapy for MS or were wait-listed while continuing to receive their usual treatment for MS. The therapy group received 16 individual treatment sessions over 24 weeks, and were then followed for an additional 24 weeks.

 

The sessions included teaching problem solving skills, relaxation, increasing positive activities, cognitive restructuring, and enhancement of social support. Participants were able to tailor the treatment to meet their needs using optional treatment modules including communication and assertiveness training, fatigue management, anxiety reduction, pain management, management of cognitive problems, and insomnia treatment.

 

MRIs were performed at the start of the study as well as at weeks 8, 16, 24, 32, 40 and 48. They revealed that while lesions were prevented or reduced during stress therapy, the benefit did not continue beyond treatment. Possible explanations include the need for longer, or possibly indefinite stress management therapy, participants‘ inability to sustain coping skills once the support of active treatment ended, or that the experience of a supportive relationship was responsible for the changes.

 

"Stress management clearly improved disease activity in the treatment group – our primary finding – for the duration of therapy," concludes Dr. Lovera, "That finding lays the groundwork for further study to determine how best to continue the benefit."

 

According to the National Institutes of Health which funded the study, multiple sclerosis is an autoimmune disease that affects the brain and spinal cord (the central nervous system.) Caused by damage to the myelin sheath that covers and protects nerve cells, the resulting inflammation slows down or stops signals from the nerves. MS affects women more than men. Symptoms range from loss of balance and problems moving arms and legs to double or loss of vision and trouble chewing or swallowing. There is currently no cure.

 

 

In addition to LSU Health Sciences Center New Orleans, the team included researchers from the Northwestern University Feinberg School of Medicine, Evergreen Hospital Medical Center, the University of California, San Francisco, and the San Francisco VA Medical Center.

 

LSU Health Sciences Center New Orleans educates Louisiana’s health care professionals. The state’s academic health leader, LSUHSC New Orleans consists of a School of Medicine, the state’s only School of Dentistry, Louisiana’s only public School of Public Health, Schools of Allied Health Professions and Graduate Studies, and the only School of Nursing within an academic health center in the State of Louisiana. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth

 


 

Louisiana State University Health Sciences Center, 16.07.2012 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…